The early IVF “fathers” were true visionaries who predicted the therapeutic use of preimplantation genetic diagnosis (PGD) as early as the 1960s. They immediately realized the possibility and desirability of determining an embryo’s genetic normalcy prior to transfer.1
Sponsor
This supplement is sponsored by Actavis.
Author and Disclosure Information
Carol B. Lesser, MSN, RNC, NP, is a Nurse Practitioner at Boston IVF, Boston, MA.
Maryellen Matthews, RNC, is a Nurse Coordinator at Reproductive Medicine Associates of New Jersey (RMANJ) and is based in its Basking Ridge, NJ office.
Ms Lesser discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.
Ms Matthews discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.
Carol B. Lesser, MSN, RNC, NP, is a Nurse Practitioner at Boston IVF, Boston, MA.
Maryellen Matthews, RNC, is a Nurse Coordinator at Reproductive Medicine Associates of New Jersey (RMANJ) and is based in its Basking Ridge, NJ office.
Ms Lesser discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.
Ms Matthews discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.
Author and Disclosure Information
Carol B. Lesser, MSN, RNC, NP, is a Nurse Practitioner at Boston IVF, Boston, MA.
Maryellen Matthews, RNC, is a Nurse Coordinator at Reproductive Medicine Associates of New Jersey (RMANJ) and is based in its Basking Ridge, NJ office.
Ms Lesser discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.
Ms Matthews discloses that she received compensation from Actavis, Inc. for her participation in the preparation of this newsletter.
Sponsor
This supplement is sponsored by Actavis.
Sponsor
This supplement is sponsored by Actavis.
The early IVF “fathers” were true visionaries who predicted the therapeutic use of preimplantation genetic diagnosis (PGD) as early as the 1960s. They immediately realized the possibility and desirability of determining an embryo’s genetic normalcy prior to transfer.1
The early IVF “fathers” were true visionaries who predicted the therapeutic use of preimplantation genetic diagnosis (PGD) as early as the 1960s. They immediately realized the possibility and desirability of determining an embryo’s genetic normalcy prior to transfer.1
